Immediate Impact
56 standout
Citing Papers
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Servando Cardona‐Huerta being referenced
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Servando Cardona‐Huerta | 480 | 71 | 237 | 359 | 39 | 894 | |
| Reginald P. Pugh | 578 | 51 | 219 | 269 | 34 | 1.1k | |
| Jeffrey W. Prichard | 288 | 123 | 142 | 288 | 38 | 899 | |
| F Badellino | 384 | 75 | 324 | 411 | 65 | 1.0k | |
| Antonio Febbraro | 636 | 78 | 239 | 310 | 56 | 1.2k | |
| Yeu‐Tsu N. Lee | 609 | 92 | 175 | 338 | 56 | 1.0k | |
| Elias Sanidas | 292 | 68 | 185 | 256 | 43 | 913 | |
| Jürgen Breul | 257 | 152 | 121 | 601 | 43 | 956 | |
| Joanna Dewar | 491 | 68 | 219 | 384 | 22 | 935 | |
| Hossein Saboorian | 445 | 53 | 365 | 381 | 24 | 1.1k | |
| Véronique Verrièle | 387 | 43 | 371 | 227 | 34 | 898 |
All Works
Login with ORCID to disown or claim papers
Loading papers...